In an inducible KRASG12D pancreatic cancer mouse model, the amplification and overexpression of the transcriptional coactivator Yap1 has been demonstrated to be a potential KRAS independent bypass mechanism (55). This evidence concerns the gene KRAS and pancreatic neoplasm.